Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Mito

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Biorxiv : the Preprint Server for Biology|November 1, 2024
An attractor state zone precedes neural crest fate in melanoma initiationAlicia M McConnell, Maggie H Chassé, Haley R Noonan, et al.
The American Journal of Surgical Pathology|April 24, 2018
Immunohistochemical Detection and Molecular Characterization of IDH-mutant Sinonasal Undifferentiated CarcinomasJeffrey K Mito, Justin A Bishop, Peter M Sadow, et al.
Blood|February 27, 2008
DDX3Y encodes a class I MHC-restricted H-Y antigen that is expressed in leukemic stem cellsKellie V Rosinski, Nobuharu Fujii, Jeffrey K Mito, et al.
Blood|January 5, 2006
The PANE1 gene encodes a novel human minor histocompatibility antigen that is selectively expressed in B-lymphoid cells and B-CLLAnthony G Brickner, Anne M Evans, Jeffrey K Mito, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2008
C19orf48 encodes a minor histocompatibility antigen recognized by CD8+ cytotoxic T cells from renal cell carcinoma patientsScott S Tykodi, Nobuharu Fujii, Nathalie Vigneron, et al.
Plos One|December 4, 2009
Cross species genomic analysis identifies a mouse model as undifferentiated pleomorphic sarcoma/malignant fibrous histiocytomaJeffrey K Mito, Richard F Riedel, Leslie Dodd, et al.
Elife|February 2, 2021
SATB2 induction of a neural crest mesenchyme-like program drives melanoma invasion and drug resistanceMaurizio Fazio, Ellen van Rooijen, Michelle Dang, et al.
Blood|January 15, 2010
Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigensEdus H Warren, Nobuharu Fujii, Yoshiki Akatsuka, et al.
Oral Oncology|June 6, 2021
A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinomaGlenn J Hanna, Anne ONeill, Jennifer M Cutler, et al.
Cancer|March 23, 2012
Intraoperative detection and removal of microscopic residual sarcoma using wide-field imagingJeffrey K Mito, Jorge M Ferrer, Brian E Brigman, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Biorxiv : the Preprint Server for Biology|November 1, 2024
An attractor state zone precedes neural crest fate in melanoma initiationAlicia M McConnell, Maggie H Chassé, Haley R Noonan, et al.
The American Journal of Surgical Pathology|April 24, 2018
Immunohistochemical Detection and Molecular Characterization of IDH-mutant Sinonasal Undifferentiated CarcinomasJeffrey K Mito, Justin A Bishop, Peter M Sadow, et al.
Blood|February 27, 2008
DDX3Y encodes a class I MHC-restricted H-Y antigen that is expressed in leukemic stem cellsKellie V Rosinski, Nobuharu Fujii, Jeffrey K Mito, et al.
Blood|January 5, 2006
The PANE1 gene encodes a novel human minor histocompatibility antigen that is selectively expressed in B-lymphoid cells and B-CLLAnthony G Brickner, Anne M Evans, Jeffrey K Mito, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2008
C19orf48 encodes a minor histocompatibility antigen recognized by CD8+ cytotoxic T cells from renal cell carcinoma patientsScott S Tykodi, Nobuharu Fujii, Nathalie Vigneron, et al.
Plos One|December 4, 2009
Cross species genomic analysis identifies a mouse model as undifferentiated pleomorphic sarcoma/malignant fibrous histiocytomaJeffrey K Mito, Richard F Riedel, Leslie Dodd, et al.
Elife|February 2, 2021
SATB2 induction of a neural crest mesenchyme-like program drives melanoma invasion and drug resistanceMaurizio Fazio, Ellen van Rooijen, Michelle Dang, et al.
Blood|January 15, 2010
Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigensEdus H Warren, Nobuharu Fujii, Yoshiki Akatsuka, et al.
Oral Oncology|June 6, 2021
A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinomaGlenn J Hanna, Anne ONeill, Jennifer M Cutler, et al.
Cancer|March 23, 2012
Intraoperative detection and removal of microscopic residual sarcoma using wide-field imagingJeffrey K Mito, Jorge M Ferrer, Brian E Brigman, et al.
Pageof 11